Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource Savings

• Published in: International journal of environmental research and public health 2021-07, Vol.18 (13), p.7129
• Main Authors: López Seguí, Francesc, Navarrete Duran, Jose Maria, Tuldrà, Albert, Sarquella, Maria, Revollo, Boris, Llibre, Josep Maria, Ara del Rey, Jordi, Estrada Cuxart, Oriol, Paredes Deirós, Roger, Hernández Guillamet, Guillem, Clotet Sala, Bonaventura, Vidal Alaball, Josep, Such Faro, Patricia
• Format: Article
• Language: English
• Subjects: Antigens; Asymptomatic; Automobile industry; Coronaviruses; Cost control; Costs; COVID-19; COVID-19 diagnostic tests; Disease transmission; Economic impact; Epidemics; Epidemiology; Health care; Health care industry; Hospitalization; Impact analysis; Industrial production; Manufacturers; Morbidity; Mortality; Occupational health; Pandemics; Patient admissions; Population; Private sector; Public health; Quarantine; Risk reduction; Severe acute respiratory syndrome coronavirus 2; Viruses; Workers
• ISSN: 1660-4601; 1661-7827; 1660-4601
• DOI: 10.3390/ijerph18137129

Background: The epidemiological situation generated by COVID-19 has cast into sharp relief the delicate balance between public health priorities and the economy, with businesses obliged to toe the line between employee health and continued production. In an effort to detect as many cases as possible, isolate contacts, cut transmission chains, and limit the spread of the virus in the workplace, mass testing strategies have been implemented in both public health and industrial contexts to minimize the risk of disruption in activity. Objective: To evaluate the economic impact of the mass workplace testing strategy as carried out by a large automotive company in Catalonia in terms of health and healthcare resource savings. Methodology: Analysis of health costs and impacts based on the estimation of the mortality and morbidity avoided because of screening, and the resulting savings in healthcare costs. Results: The economic impact of the mass workplace testing strategies (using both PCR and RAT tests) was approximately €10.44 per test performed or €5575.49 per positive detected; 38% of this figure corresponds to savings derived from better use of health resources (hospital beds, ICU beds, and follow-up of infected cases), while the remaining 62% corresponds to improved health rates due to the avoided morbidity and mortality. In scenarios with higher positivity rates and a greater impact of the infection on health and the use of health resources, these results could be up to ten times higher (€130.24 per test performed or €69,565.59 per positive detected). Conclusion: In the context of COVID-19, preventive actions carried out by the private sector to safeguard industrial production also have concomitant public benefits in the form of savings in healthcare costs. Thus, governmental bodies need to recognize the value of implementing such strategies in private settings and facilitate them through, for example, subsidies.